Skip to main content

Blueprint Medicines Corp

BPMCDelisted Jul 18, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597264

Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Blueprint Medicines Corp changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of BPMC: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders2601282+23
Shares64.1M20265.9M+1.79M (+2.8%)
Value$5.91B$18.6K$6.25B+$335.8M (+5.7%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held Blueprint Medicines Corp at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to BPMC in Q1 2024
InstitutionSharesValue% of portfolio
Holocene Advisors, LP715,303$67.9M0.25%
Marshall Wace, LLP230,292$21.8M0.04%
Driehaus Capital Management LLC178,212$16.9M0.17%
Ally Bridge Group (NY) LLC160,950$15.3M8.49%
Redmile Group, LLC113,060$10.7M0.39%
Ghost Tree Capital, LLC72,761$6.90M2.22%
Jacobs Levy Equity Management, Inc71,441$6.78M0.03%
Hillsdale Investment Management Inc.53,470$5.07M0.40%
Renaissance Technologies LLC47,500$4.51M0.01%
First Trust Advisors LP47,271$4.48M0.00%
ExodusPoint Capital Management, LP21,041$2.00M0.02%
Fred Alger Management, LLC16,913$1.60M0.01%
Brevan Howard Capital Management LP10,123$960.3K0.09%
Cetera Investment Advisers8,321$789.3K0.00%
Calamos Advisors LLC8,156$773.7K0.00%
Options Solutions, LLC7,802$740.1K0.42%
S&CO Inc6,700$635.0K0.04%
J. Goldman & Co LP5,228$495.9K0.02%
Bellevue Group AG5,100$483.8K0.01%
Susquehanna Fundamental Investments, LLC5,000$474.3K0.02%
Prime Capital Investment Advisors, LLC4,769$452.4K0.01%
Aigen Investment Management, LP4,624$438.6K0.10%
Ellsworth Advisors, LLC4,843$422.6K0.12%
Sherbrooke Park Advisers LLC3,133$297.2K0.06%
Cerity Partners LLC2,877$272.9K0.00%
Simplex Trading, LLC2,715$257.0K0.01%
Lazard Asset Management LLC2,658$251.0K0.00%
Verition Fund Management LLC2,465$233.8K0.00%
Kennedy Capital Management, Inc.2,320$220.1K0.00%
Allspring Global Investments Holdings, LLC2,303$218.5K0.00%
Baader Bank INC2,200$208.7K0.02%
Quest Partners LLC1,698$161.1K0.03%
Walleye Capital LLC1,588$150.6K0.00%
IFP Advisors, Inc1,105$104.8K0.00%
Gilliland Jeter Wealth Management LLC900$85.4K0.03%
Catalyst Funds Management Pty Ltd800$75.9K0.02%
Natixis768$72.9K0.00%
Allianz SE700$66.4K0.00%
Pacer Advisors, Inc.463$43.9K0.00%
Fernwood Investment Management, LLC404$38.3K0.01%
Rise Advisors, LLC156$14.8K0.01%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC131$12.4K0.00%
Continuum Advisory, LLC37$4.01K0.00%
Meeder Asset Management Inc31$2.94K0.00%
Hollencrest Capital Management30$2.85K0.00%
AdvisorNet Financial, Inc15$1.42K0.00%
Riggs Asset Managment Co. Inc.12$1.14K0.00%
Assetmark, Inc6$5690.00%
Rothschild Investment LLC5$4740.00%
Rakuten Securities, Inc.5$4740.00%
Sofos Investments, Inc.4$3620.00%

Sold out (28)

Institutions that held Blueprint Medicines Corp at the end of Q4 2023 and filed for Q1 2024 without it.

Not filed for Q1 2024 yet (1)

Institutions that held Blueprint Medicines Corp at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BPMC in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Coppell Advisory Solutions LLC202$18.6K